ROYAL BANK OF CANADA - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$5,000
+66.7%
1,815
+83.7%
0.00%
Q2 2023$3,000
+200.0%
988
+156.6%
0.00%
Q1 2023$1,000385
+285.0%
0.00%
Q4 2022$0
-100.0%
100
-96.7%
0.00%
Q1 2022$9,000
-65.4%
3,044
-65.0%
0.00%
Q4 2021$26,000
-49.0%
8,705
+20.1%
0.00%
Q3 2021$51,000
-12.1%
7,251
+15.8%
0.00%
Q2 2021$58,000
-27.5%
6,264
-24.6%
0.00%
Q1 2021$80,000
+50.9%
8,306
+64.4%
0.00%
Q4 2020$53,000
+10.4%
5,053
+7.5%
0.00%
Q3 2020$48,000
-83.2%
4,700
-82.8%
0.00%
Q2 2020$285,000
-34.3%
27,352
-46.9%
0.00%
Q1 2020$434,000
+77.9%
51,479
+84.1%
0.00%
Q4 2019$244,000
+86.3%
27,960
+129.7%
0.00%
Q3 2019$131,000
+36.5%
12,175
+60.0%
0.00%
Q2 2019$96,000
-11.1%
7,608
+171.3%
0.00%
Q1 2019$108,000
+56.5%
2,804
-18.3%
0.00%
Q4 2018$69,000
-72.1%
3,431
-36.3%
0.00%
Q3 2018$247,000
-16.0%
5,387
+8.1%
0.00%
Q2 2018$294,000
+7.7%
4,985
+24.0%
0.00%
Q1 2018$273,000
+155.1%
4,021
+271.3%
0.00%
Q4 2017$107,000
-72.7%
1,083
-66.9%
0.00%
Q3 2017$392,000
+734.0%
3,274
+523.6%
0.00%
Q2 2017$47,000
-9.6%
525
-62.7%
0.00%
Q1 2017$52,000
+2.0%
1,408
-15.5%
0.00%
Q4 2016$51,000
+54.5%
1,666
+236.6%
0.00%
Q3 2016$33,000
+22.2%
495
-46.5%
0.00%
Q2 2016$27,000
-69.3%
925
-69.1%
0.00%
Q1 2016$88,000
+23.9%
2,991
+232.7%
0.00%
Q4 2015$71,000
-5.3%
899
-9.3%
0.00%
Q3 2015$75,000
-69.9%
991
-53.6%
0.00%
Q2 2015$249,000
-78.0%
2,138
-55.5%
0.00%
-100.0%
Q1 2015$1,134,000
+212.4%
4,803
+150.7%
0.00%
Q4 2014$363,000
+41.8%
1,916
+78.4%
0.00%
Q3 2014$256,000
+20.2%
1,074
-66.7%
0.00%
Q2 2014$213,000
-57.0%
3,225
-32.1%
0.00%
Q1 2014$495,000
-85.0%
4,750
-85.1%
0.00%
-100.0%
Q4 2013$3,304,000
+7.7%
31,909
-44.2%
0.00%0.0%
Q3 2013$3,069,000
+70.8%
57,200
+41.2%
0.00%0.0%
Q2 2013$1,797,00040,5000.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$12,636,0002.61%
AIGH Capital Management LLC 964,590$9,376,0001.97%
Worth Venture Partners, LLC 226,758$2,204,0001.07%
Camber Capital Management LP 2,555,000$24,835,0000.85%
Palo Alto Investors LP 1,392,997$13,540,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,769,795$36,642,0000.77%
GLOBEFLEX CAPITAL L P 428,680$4,167,0000.76%
Zebra Capital Management LLC 34,243$333,0000.37%
Sofinnova Investments, Inc. 344,917$3,353,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 605,792$5,888,0000.19%
View complete list of PUMA BIOTECHNOLOGY INC shareholders